Fairvalue-Calculator Fairvalue-Calculator
EN DE

Zomedica Corp (ZOMDF) Fair Value & Analysis

Healthcare · US · Market cap $98.0M

Price$0.0950
Fair Value$0.0523
Upside-45.0%
Quality95/100
Evidence: Low Range $0.0428 – $0.0713

Fair value as of: Jun 26, 2026

Analysis

Zomedica Corp (ZOMDF) currently trades at $0.0950, while our model-based Fair Value estimate is $0.0523 — implying the stock looks roughly 45.0% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. It offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system. The company provides therapeutic products, including PulseVet electrohydraulic shockwave therapy platform; and Assisi Loop line of products, including the Assisi Loop, Assisi Loop Lounge, Assisi EquiLoop, and DentaLoop devices that treat pain and inflammation through delivery of targeted pulsed electromagnetic field focused energy. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. is headquartered in Ann Arbor, Michigan.

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -9% Stryker Corporation (S1YK34) -45% Medtronic plc (MDT) -7% Boston Scientific Corporation (B1SX34) -5% Edwards Lifesciences Corporation (EW) -52% Siemens Healthineers AG (SEMHF) +11%

Frequently asked questions

Is Zomedica Corp (ZOMDF) undervalued?
As of Jun 26, 2026, our model estimates a fair value of $0.0523 versus a price of $0.0950 — about −45% (overvalued). Model-based estimate, not financial advice.
What is the fair value of ZOMDF?
Our 21-model fair value for Zomedica Corp is $0.0523 (as of Jun 26, 2026), built from audited fundamentals. The current price is $0.0950.
What is the quality score of ZOMDF?
Zomedica Corp has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.